Merit Medical Systems, Inc. (MMSI)
USD 88.48
(-4.36%)
USD 88.48
(-4.36%)
| Year | Net Debt | Net Debt Growth |
|---|---|---|
| 2023 | 302.22 Million USD | 43.68% |
| 2022 | 210.34 Million USD | -14.94% |
| 2021 | 247.27 Million USD | -34.61% |
| 2020 | 378.15 Million USD | -21.12% |
| 2019 | 479.42 Million USD | 46.26% |
| 2018 | 327.79 Million USD | 33.18% |
| 2017 | 246.13 Million USD | -19.35% |
| 2016 | 305.2 Million USD | 50.04% |
| 2015 | 203.41 Million USD | -6.32% |
| 2014 | 217.13 Million USD | -10.05% |
| 2013 | 241.39 Million USD | 5.95% |
| 2012 | 227.84 Million USD | 1005.57% |
| 2011 | 20.6 Million USD | -73.51% |
| 2010 | 77.8 Million USD | 8873.82% |
| 2009 | 867 Thousand USD | 102.58% |
| 2008 | -33.66 Million USD | -96.23% |
| 2007 | -17.15 Million USD | -78.08% |
| 2006 | -9.63 Million USD | -107.56% |
| 2005 | -4.64 Million USD | 85.95% |
| 2004 | -33.02 Million USD | -9.4% |
| 2003 | -30.18 Million USD | -225.76% |
| 2002 | -9.26 Million USD | -254.86% |
| 2001 | 5.98 Million USD | -75.77% |
| 2000 | 24.69 Million USD | -24.72% |
| 1999 | 32.8 Million USD | 175.63% |
| 1998 | 11.9 Million USD | 27.96% |
| 1997 | 9.3 Million USD | -1.06% |
| 1996 | 9.4 Million USD | 16.05% |
| 1995 | 8.1 Million USD | 84.09% |
| 1994 | 4.4 Million USD | 214.29% |
| 1993 | 1.4 Million USD | 333.33% |
| 1992 | -600 Thousand USD | -50.0% |
| 1991 | -400 Thousand USD | 33.33% |
| 1990 | -600 Thousand USD | -400.0% |
| 1989 | 200 Thousand USD | 0.0% |
| Year | Net Debt | Net Debt Growth |
|---|---|---|
| 2024 Q3 | 227.37 Million USD | 27.38% |
| 2024 Q1 | 290.82 Million USD | -3.77% |
| 2024 Q2 | 232.38 Million USD | -20.09% |
| 2023 FY | 302.22 Million USD | 43.68% |
| 2023 Q4 | 302.22 Million USD | 1.9% |
| 2023 Q1 | 208.51 Million USD | -0.87% |
| 2023 Q2 | 335.02 Million USD | 60.67% |
| 2023 Q3 | 296.59 Million USD | -11.47% |
| 2022 FY | 210.34 Million USD | -14.94% |
| 2022 Q2 | 253.1 Million USD | -6.01% |
| 2022 Q4 | 210.34 Million USD | -10.68% |
| 2022 Q3 | 235.48 Million USD | -6.96% |
| 2022 Q1 | 269.28 Million USD | 8.9% |
| 2021 Q2 | 300.29 Million USD | -12.22% |
| 2021 FY | 247.27 Million USD | -34.61% |
| 2021 Q4 | 247.27 Million USD | -13.05% |
| 2021 Q3 | 284.4 Million USD | -5.29% |
| 2021 Q1 | 342.08 Million USD | -9.54% |
| 2020 FY | 378.15 Million USD | -21.12% |
| 2020 Q1 | 478.86 Million USD | -0.12% |
| 2020 Q4 | 378.15 Million USD | -4.3% |
| 2020 Q3 | 395.15 Million USD | -11.28% |
| 2020 Q2 | 445.38 Million USD | -6.99% |
| 2019 Q4 | 479.42 Million USD | -1.42% |
| 2019 Q1 | 418.73 Million USD | 27.74% |
| 2019 Q3 | 486.34 Million USD | 8.55% |
| 2019 Q2 | 448.04 Million USD | 7.0% |
| 2019 FY | 479.42 Million USD | 46.26% |
| 2018 Q4 | 327.79 Million USD | 108.9% |
| 2018 Q2 | 370.05 Million USD | 5.02% |
| 2018 Q3 | 156.91 Million USD | -57.6% |
| 2018 Q1 | 352.35 Million USD | 43.16% |
| 2018 FY | 327.79 Million USD | 33.18% |
| 2017 Q2 | 204.23 Million USD | -3.18% |
| 2017 Q4 | 246.13 Million USD | -3.32% |
| 2017 FY | 246.13 Million USD | -19.35% |
| 2017 Q1 | 210.94 Million USD | -30.88% |
| 2017 Q3 | 254.57 Million USD | 24.65% |
| 2016 Q2 | 221.23 Million USD | -0.9% |
| 2016 Q1 | 223.24 Million USD | 9.75% |
| 2016 Q3 | 310.44 Million USD | 40.32% |
| 2016 FY | 305.2 Million USD | 50.04% |
| 2016 Q4 | 305.2 Million USD | -1.69% |
| 2015 Q4 | 203.41 Million USD | -0.46% |
| 2015 Q1 | 202.97 Million USD | -6.52% |
| 2015 FY | 203.41 Million USD | -6.32% |
| 2015 Q3 | 204.35 Million USD | 3.38% |
| 2015 Q2 | 197.67 Million USD | -2.61% |
| 2014 FY | 217.13 Million USD | -10.05% |
| 2014 Q4 | 217.13 Million USD | -7.35% |
| 2014 Q3 | 234.36 Million USD | -1.93% |
| 2014 Q2 | 238.97 Million USD | -1.19% |
| 2014 Q1 | 241.85 Million USD | 0.19% |
| 2013 Q3 | 242.04 Million USD | -0.67% |
| 2013 Q4 | 241.39 Million USD | -0.27% |
| 2013 FY | 241.39 Million USD | 5.95% |
| 2013 Q1 | 245.23 Million USD | 7.63% |
| 2013 Q2 | 243.68 Million USD | -0.63% |
| 2012 Q4 | 227.84 Million USD | 260.88% |
| 2012 FY | 227.84 Million USD | 1005.57% |
| 2012 Q2 | 54.76 Million USD | 8.33% |
| 2012 Q1 | 50.55 Million USD | 112.1% |
| 2012 Q3 | 63.13 Million USD | 15.28% |
| 2011 Q2 | -8 Million USD | -110.13% |
| 2011 Q4 | 23.83 Million USD | 12017.5% |
| 2011 FY | 20.6 Million USD | -73.51% |
| 2011 Q1 | 79.09 Million USD | -0.05% |
| 2011 Q3 | -200 Thousand USD | 97.5% |
| 2010 Q3 | 82.69 Million USD | 2171.94% |
| 2010 FY | 77.8 Million USD | 8873.82% |
| 2010 Q2 | -3.99 Million USD | -885.63% |
| 2010 Q1 | 508 Thousand USD | -58.05% |
| 2010 Q4 | 79.13 Million USD | -4.3% |
| 2009 Q3 | -5.3 Million USD | -18.16% |
| 2009 Q4 | 1.21 Million USD | 122.84% |
| 2009 FY | 867 Thousand USD | 102.58% |
| 2009 Q2 | -4.48 Million USD | 72.02% |
| 2009 Q1 | -16.03 Million USD | 52.88% |
| 2008 Q4 | -34.03 Million USD | -9.49% |
| 2008 Q2 | -26.38 Million USD | -12.91% |
| 2008 Q3 | -31.08 Million USD | -17.8% |
| 2008 FY | -33.66 Million USD | -96.23% |
| 2008 Q1 | -23.36 Million USD | -32.97% |
| 2007 Q3 | -11.76 Million USD | -34.4% |
| 2007 Q4 | -17.57 Million USD | -49.39% |
| 2007 Q2 | -8.75 Million USD | 7.54% |
| 2007 Q1 | -9.46 Million USD | 3.77% |
| 2007 FY | -17.15 Million USD | -78.08% |
| 2006 Q3 | -7 Million USD | 8.36% |
| 2006 FY | -9.63 Million USD | -107.56% |
| 2006 Q1 | -9 Million USD | -94.12% |
| 2006 Q2 | -7.64 Million USD | 15.2% |
| 2006 Q4 | -9.83 Million USD | -40.52% |
| 2005 Q2 | -18.82 Million USD | 34.19% |
| 2005 FY | -4.64 Million USD | 85.95% |
| 2005 Q4 | -4.64 Million USD | 61.23% |
| 2005 Q3 | -11.97 Million USD | 36.41% |
| 2005 Q1 | -28.6 Million USD | 13.38% |
| 2004 Q2 | -35.86 Million USD | -5.82% |
| 2004 Q1 | -33.89 Million USD | -12.28% |
| 2004 FY | -33.02 Million USD | -9.4% |
| 2004 Q3 | -34.43 Million USD | 3.99% |
| 2004 Q4 | -33.02 Million USD | 4.09% |
| 2003 Q2 | -20.6 Million USD | -29.94% |
| 2003 Q4 | -30.18 Million USD | -15.06% |
| 2003 Q3 | -26.23 Million USD | -27.33% |
| 2003 FY | -30.18 Million USD | -225.76% |
| 2003 Q1 | -15.85 Million USD | -71.11% |
| 2002 FY | -9.26 Million USD | -254.86% |
| 2002 Q1 | 142.67 Thousand USD | -97.62% |
| 2002 Q4 | -9.26 Million USD | -57.69% |
| 2002 Q3 | -5.87 Million USD | -98.44% |
| 2002 Q2 | -2.96 Million USD | -2175.62% |
| 2001 FY | 5.98 Million USD | -75.77% |
| 2001 Q1 | 20.46 Million USD | -17.12% |
| 2001 Q3 | 8.55 Million USD | -43.66% |
| 2001 Q2 | 15.18 Million USD | -25.8% |
| 2001 Q4 | 5.98 Million USD | -30.05% |
| 2000 Q2 | 31.19 Million USD | 4.2% |
| 2000 Q1 | 29.94 Million USD | -8.71% |
| 2000 FY | 24.69 Million USD | -24.72% |
| 2000 Q4 | 24.69 Million USD | -17.32% |
| 2000 Q3 | 29.86 Million USD | -4.29% |
| 1999 Q2 | 12.4 Million USD | -1.59% |
| 1999 Q3 | 24.5 Million USD | 97.58% |
| 1999 FY | 32.8 Million USD | 175.63% |
| 1999 Q4 | 32.8 Million USD | 33.88% |
| 1999 Q1 | 12.6 Million USD | 5.88% |
| 1998 Q1 | 10.3 Million USD | 10.75% |
| 1998 FY | 11.9 Million USD | 27.96% |
| 1998 Q2 | 9.4 Million USD | -8.74% |
| 1998 Q3 | 10.2 Million USD | 8.51% |
| 1998 Q4 | 11.9 Million USD | 16.67% |
| 1997 Q2 | 10.2 Million USD | 0.99% |
| 1997 Q1 | 10.1 Million USD | 7.45% |
| 1997 Q3 | 11 Million USD | 7.84% |
| 1997 Q4 | 9.3 Million USD | -15.45% |
| 1997 FY | 9.3 Million USD | -1.06% |
| 1996 Q4 | 9.4 Million USD | -4.08% |
| 1996 Q2 | 9.6 Million USD | 1.05% |
| 1996 Q1 | 9.5 Million USD | 17.28% |
| 1996 FY | 9.4 Million USD | 16.05% |
| 1996 Q3 | 9.8 Million USD | 2.08% |
| 1995 Q3 | 5.9 Million USD | -13.24% |
| 1995 Q4 | 8.1 Million USD | 37.29% |
| 1995 Q1 | 4.9 Million USD | 11.36% |
| 1995 Q2 | 6.8 Million USD | 38.78% |
| 1995 FY | 8.1 Million USD | 84.09% |
| 1994 Q1 | 3.8 Million USD | 171.43% |
| 1994 FY | 4.4 Million USD | 214.29% |
| 1994 Q4 | 4.4 Million USD | 2.33% |
| 1994 Q3 | 4.3 Million USD | 13.16% |
| 1994 Q2 | 3.8 Million USD | 0.0% |
| 1993 Q1 | 400 Thousand USD | 166.67% |
| 1993 Q3 | 100 Thousand USD | -80.0% |
| 1993 FY | 1.4 Million USD | 333.33% |
| 1993 Q4 | 1.4 Million USD | 1300.0% |
| 1993 Q2 | 500 Thousand USD | 25.0% |
| 1992 FY | -600 Thousand USD | -50.0% |
| 1992 Q1 | 300 Thousand USD | 175.0% |
| 1992 Q2 | -2.9 Million USD | -1066.67% |
| 1992 Q3 | -1.5 Million USD | 48.28% |
| 1992 Q4 | -600 Thousand USD | 60.0% |
| 1991 Q3 | -1 Million USD | 0.0% |
| 1991 FY | -400 Thousand USD | 33.33% |
| 1991 Q4 | -400 Thousand USD | 60.0% |
| 1990 FY | -600 Thousand USD | -400.0% |
| 1990 Q4 | -600 Thousand USD | 0.0% |
| 1989 Q4 | 200 Thousand USD | 0.0% |
| 1989 FY | 200 Thousand USD | 0.0% |
| Name | Net Debt | Net Debt Difference |
|---|---|---|
| Akoya Biosciences, Inc. | 2.58 Million USD | -11609.531% |
| AngioDynamics, Inc. | -70.14 Million USD | 530.873% |
| AtriCure, Inc. | -9.81 Million USD | 3178.881% |
| Avinger, Inc. | 10.12 Million USD | -2886.393% |
| Azenta, Inc. | -618.47 Million USD | 148.866% |
| BioLife Solutions, Inc. | 7.25 Million USD | -4066.869% |
| The Cooper Companies, Inc. | 2.44 Billion USD | 87.656% |
| Daxor Corporation | 755.65 Thousand USD | -39894.627% |
| Ekso Bionics Holdings, Inc. | -1.47 Million USD | 20659.388% |
| Femasys Inc. | -15.01 Million USD | 2112.781% |
| GlucoTrack, Inc. | -4.29 Million USD | 7134.986% |
| Harvard Bioscience, Inc. | 38.49 Million USD | -685.199% |
| Hologic, Inc. | 374.4 Million USD | 19.278% |
| ICU Medical, Inc. | 1.45 Billion USD | 79.164% |
| Intuitive Surgical, Inc. | -2.66 Billion USD | 111.36% |
| KORU Medical Systems, Inc. | -7.03 Million USD | 4394.697% |
| LeMaitre Vascular, Inc. | -5.17 Million USD | 5941.187% |
| Innovative Eyewear, Inc. | -4.28 Million USD | 7149.02% |
| Innovative Eyewear, Inc. | -4.28 Million USD | 7149.02% |
| Masimo Corporation | 804 Million USD | 62.41% |
| Microbot Medical Inc. | -2.28 Million USD | 13320.604% |
| Meihua International Medical Technologies Co., Ltd. | -9.59 Million USD | 3249.553% |
| Nephros, Inc. | -2.47 Million USD | 12330.797% |
| NovoCure Limited | 355.42 Million USD | 14.968% |
| NEXGEL, Inc. | 98 Thousand USD | -308290.816% |
| NEXGEL, Inc. | 98 Thousand USD | -308290.816% |
| Singular Genomics Systems, Inc. | 59.05 Million USD | -411.765% |
| OraSure Technologies, Inc. | -276.9 Million USD | 209.144% |
| Pro-Dex, Inc. | 10.91 Million USD | -2668.624% |
| Pulse Biosciences, Inc. | -35.22 Million USD | 958.076% |
| Predictive Oncology Inc. | -5.87 Million USD | 5246.984% |
| Precision Optics Corporation, Inc. | 3.02 Million USD | -9877.047% |
| QuidelOrtho Corporation | 2.49 Billion USD | 87.888% |
| Repligen Corporation | -39.51 Million USD | 864.754% |
| Sanara MedTech Inc. | 6.64 Million USD | -4448.199% |
| STAAR Surgical Company | -147.2 Million USD | 305.309% |
| Sharps Technology, Inc. | -3.01 Million USD | 10130.94% |
| Utah Medical Products, Inc. | -92.52 Million USD | 426.636% |
| DENTSPLY SIRONA Inc. | 1.96 Billion USD | 84.62% |
| Jin Medical International Ltd. | -2.81 Million USD | 10830.415% |